Omnicell (OMCL) Company Overview

Omnicell, Inc. (NASDAQ:OMCL ) Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President, Investor Relations Randall Lipps - Founder, Chairman, President and Chief Executive Officer Nchacha Etta - Executive Vice President and Chief Financial Officer Conference Call Participants Allen Lutz - Bank of America Jessica Datson - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Scott Schoenhaus - KeyBanc Capital Markets Stan Berenshteyn - Wells Fargo David Larsen - BTIG Gene Mannheimer - Freedom Capital Markets Operator Thank you for standing by. My name is Kathleen and I will be your conference operator today.

Omnicell (OMCL) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.33 per share a year ago.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results.

OMCL stays on investors' radar due to the strong performance of the Advanced Services portfolio.

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

This Industry Outlook article has featured Enovis, Omnicell, and Phreesia.

Stocks in the Zacks Medical Info Systems sector, such as Enovis, Omnicell, and Phreesia, are likely to benefit from the rise of GenAI technology.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025.

Omnicell (OMCL) stock has begun to rise and may keep increasing soon, based on positive changes in earnings forecasts.